|NPI just completed the construction of a 1800 sq meter GMP|
|manufacturing facility (US-Kelly Pharma) in Zhengzhou, China.|
|NPI-BC-4-1, a potent topoisomerase I inhibitor and cell|
|differentiation inducer, was isolated and identified as a potential |
anti-cancer agent for prostate and brain tumors.
|Recently, NPI obtained one additional natural remedy (kazoom: liver|
|protection ) approved by China FDA.|
|Recent work on the development of an herbal suppressor of alcohol|
|drinking resulted in the discovery of NPI-031G as a potential anti-|
craving agent for the treatment of alcoholism, a major social and
health problem in the U.S. and around the world.